B.

b.value AG

VC
Portfolio

6+ companies

Team

5 partners

Investor activity
Investments in last 12 months: 0

Meet the Team

DP

Dipl.-Kfm. Peter Kallien

Managing Director

DG

Dr. Georg Lentzen

Managing Director

DC

Dr. Cornelia Bähr

Senior Investment Manager

DM

Dr. Marie Kappen

Senior Investment Manager

DI

Dr. Isabelle Schiffer

Investment Manager

Portfolio Companies (6)

Other

FI

FibreCoat

Advanced Materials·Series A (2021), Series B (2024)

"Discovered via perplexity (medium confidence)"

Develops lightweight, conductive fiber coatings for automotive, defense, and space applications by coating metals/plastics onto fibers during spinning.

PL

PL BioScience

Biotechnology·Series A (€7.8M, 2024)

"Discovered via perplexity (medium confidence)"

Produces Human Platelet Lysate (HPL) as animal-free cell culture media for regenerative medicine and cell therapy.

FL

FluIDect

Biotechnology/Industrial Tech·Seed (multi-million, 2023)

"Discovered via perplexity (medium confidence)"

Builds SpheroScan sensors for real-time microbial contamination detection in food, biotech, and water processes.

CE

Cellbricks Therapeutics

Biotechnology·Early-stage

"Discovered via perplexity (medium confidence)"

Develops cell-based therapeutics (e.g., for tissue repair); expanded to Boston for clinical programs.

SE

SenseUP Biotechnology

Biotechnology (AgriTech)·Seed (€2.4M+ extension to €3.5M, 2025-2026)

"Discovered via perplexity (medium confidence)"

Creates dsRNA biopesticides using bacterial delivery for precise, stable crop protection.

TR

traceless materials

Advanced Materials·Series A (€36.6M+, 2023)

"Discovered via perplexity (medium confidence)"

Produces biocircular, compostable granulate from plant residues as plastic alternative for packaging.

Frequently Asked Questions

See if b.value AG is a match for your startup

Upload your pitch deck to see how well you match with b.value AG and 200+ other VC firms.